Company Asymchem Laboratories (Tianjin) Co., Ltd. OTC Markets
Stocks
ASLT.Y
US04651E1038
Pharmaceuticals
Business description: Asymchem Laboratories (Tianjin) Co., Ltd.
Number of employees: 10,617
Sales by Activity: Asymchem Laboratories (Tianjin) Co., Ltd.
| Fiscal Period: December | 2021 (CNY) | 2022 (CNY) | 2023 (CNY) | 2024 (CNY) | 2025 (CNY) |
|---|---|---|---|---|---|
Pharmaceutical Technology | 4.63B | 10.23B | 7.78B | 5.8B | 6.67B |
Geographical breakdown of sales: Asymchem Laboratories (Tianjin) Co., Ltd.
| Fiscal Period: December | 2021 (CNY) | 2022 (CNY) | 2023 (CNY) | 2024 (CNY) | 2025 (CNY) |
|---|---|---|---|---|---|
Overseas | 3.99B | 8.67B | 6.34B | 4.28B | 4.92B |
Mainland China | 640M | 1.56B | 1.44B | 1.52B | 1.75B |
Executive Committee: Asymchem Laboratories (Tianjin) Co., Ltd.
Composition of the Board of Directors: Asymchem Laboratories (Tianjin) Co., Ltd.
| Director | Title | Age | Since |
|---|---|---|---|
Rui Yang
BRD | Director/Board Member | 49 | 2011-07-17 |
Hao Hong
CHM | Chairman | 70 | 1998-10-06 |
Ye Song
BRD | Director/Board Member | 65 | 2011-07-17 |
Liang Hong
BRD | Director/Board Member | 52 | 2011-07-17 |
Xin Xin Zhi
CHM | Chairman | 46 | 2021-02-08 |
Ting Zhang
CHM | Chairman | 40 | 2014-12-04 |
Shan Shan Di
BRD | Director/Board Member | 40 | 2017-10-30 |
Da Zhang
BRD | Director/Board Member | 45 | 2018-08-06 |
Jing Yi Hou
BRD | Director/Board Member | 43 | 2021-02-08 |
Xue Jiao Sun
BRD | Director/Board Member | 43 | 2023-10-17 |
Company details: Asymchem Laboratories (Tianjin) Co., Ltd.
Asymchem Laboratories (Tianjin) Co., Ltd.
6 Dongting 3rd Street
300457, Tianjin
+
http://www.asymchem.com.cn
Other Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.67% | +5.39% | +75.21% | +127.54% | 1,111B | |
| +1.04% | +4.07% | +52.29% | +65.39% | 658B | |
| -0.17% | +5.67% | +25.60% | +80.40% | 467B | |
| +0.24% | +2.77% | +42.71% | +43.09% | 369B | |
| +0.21% | +1.05% | +25.33% | +41.42% | 301B | |
| +0.50% | +3.08% | +2.50% | +14.16% | 256B | |
| +1.03% | +5.83% | +51.11% | +72.96% | 240B | |
| +2.01% | +3.12% | -16.80% | -52.18% | 207B | |
| +0.42% | +5.63% | +27.86% | +92.24% | 182B | |
| Average | +0.21% | +4.49% | +31.76% | +53.89% | 421.22B | |
| Weighted average by Cap. | -0.24% | +4.68% | +44.27% | +73.29% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
